Dr. Alice Reed Internal Medicine – Benefits of Protandim
Dr. Alice Reed, Internal Medicine, discusses the role of Protandim, NRF2 activation and the breakthrough of Nutrigenomics as a viable approach to health and wellness.
Dr. Benedict Maniscalco, Cardiologist explains NRF1 and Nrf2 activation
Dr. Benedict Salvadore Maniscalco, M.D. explains the benefit of nutrigenomic activation of transcription factors NRF2 and NRF1 through the patented formulae of LifeVantage Protandim® Synergizers.
Since 2001, Dr. Maniscalco has been in the private practice of cardiology. He was with Tampa Heart Center in Tampa Florida in 2000 to 2001. From 1976 through 1998, he was an officer of a large multi-specialty cardiovascular group practice. He was in private practice for consultive cardiology with Health Centers of Excellence, Inc. as Chief Executive Officer in Tampa Florida from March 1998 through January 2000. From 1979 through 1996 he was co-founder of St. Joseph’s Heart Institute in Tampa, Florida and served as Chief of Cardiology, Director for Cardiac Catheterization and Director for Cardiology during his tenure. Since 1976 until early 1979, Dr. Maniscalco was on the faculty of the University of South Florida School of Medicine, Division of Cardiology in Tampa, Florida. Later in 1979, Dr. Maniscalco was recruited to establish the cardiac catheterization laboratory at St. Joseph’s hospital in Tampa. Over the past 30 years, he has been a member of numerous local, state and national professional societies. He has served as President and Governor of the Florida Chapter of the American College of Cardiology and has been involved in numerous committees dealing with socioeconomic and medical policies in both the American College of Cardiology and the Society for Cardiac Angiography and Interventions. He has been a frequent lecturer at the local, state and national level, on both clinical and non-clinical matters affecting the delivery of cardiovascular services. He has been Co-Chairman and a Director of Nanobac Pharmaceuticals, Inc. since March 30, 2006. From 1976 through 1998, he was a board member of a large multi-specialty cardiovascular group practice. He serves as the Chairman of Advisory Board at iGambit, Inc. and has been its Member of Senior Advisory Board since May 08, 2017. He serves as a Member of Scientific Advisory Board of Nanobac Life Sciences, Inc. He received his medical degree from the Duke University School of Medicine in 1967. He interned at Grady Memorial Hospital in Atlanta and did his junior and senior residencies at Emory University Affiliated Hospitals, followed by a fellowship in Cardiovascular diseases from 1973-1975. He is licensed to practice in both Florida and Georgia and is certified by the American Board of Internal Medicine and the American Sub-Specialty Board in Cardiovascular disease.
(These products are not intended to treat, cure, prevent or diagnose any disease. These statements have not been evaluated by the FDA.)
Dr. Maniscalco explains Nrf2 and Protandim’s effect on the human body at a cellular level
Dr. Benedict Maniscalco, Cardiologist, discusses Nrf2, Protandim and Nutrigenomics as they relate to health and wellness and there effect on the human body at the cellular level.
Dr. Jefferey Fannin, M.D., Neuro Scientist Examines the benefit of Protandim NRF1 and Nrf2 and Axio as demonstrated in Brain Mapping results
Health and Wellness expert Maria Williams interviews Neuroscientist Dr. Jeff Fannin on the biohacking breakthrough of nutrigenomics and Brain Mapping.